Yuming Jiang1, Xiaokun Liang2, Zhen Han3, Wei Wang4, Sujuan Xi5, Tuanjie Li3, Chuanli Chen6, Qingyu Yuan6, Na Li7, Jiang Yu3, Yaoqin Xie7, Yikai Xu6, Zhiwei Zhou4, George A Poultsides8, Guoxin Li9, Ruijiang Li10. 1. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA. 2. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA; Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; Shenzhen Colleges of Advanced Technology, University of Chinese Academy of Sciences, Shenzhen, China. 3. Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Guangzhou, China. 4. Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. 5. The Reproductive Medical Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China. 6. Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China. 7. Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; Shenzhen Colleges of Advanced Technology, University of Chinese Academy of Sciences, Shenzhen, China. 8. Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. 9. Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. 10. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: rli2@stanford.edu.
Abstract
BACKGROUND: The tumour stroma microenvironment plays an important part in disease progression and its composition can influence treatment response and outcomes. Histological evaluation of tumour stroma is limited by access to tissue, spatial heterogeneity, and temporal evolution. We aimed to develop a radiological signature for non-invasive assessment of tumour stroma and treatment outcomes. METHODS: In this multicentre, retrospective study, we analysed CT images and outcome data of 2209 patients with resected gastric cancer from five independent cohorts recruited from two centres (Nanfang Hospital of Southern Medical University [Guangzhou, China] and Sun Yat-sen University Cancer Center [Guangzhou, China]). Patients with histologically confirmed gastric cancer, at least 15 lymph nodes harvested, preoperative abdominal CT available, and complete clinicopathological and follow-up data were eligible for inclusion. Tumour tissue was collected for patients in the training cohort (321 patients), internal validation cohort one (246 patients), and external validation cohort one (128 patients). Four stroma classes were defined according to the protein expression of α-smooth muscle actin and periostin assessed by immunohistochemistry. The primary objective was to predict the histologically based stroma classes by using preoperative CT images. We trained a deep convolutional neural network model using the training cohort and tested the model in the internal and external validation cohort one. We evaluated the model's association with prognosis in the training cohort, two internal, and two external validation cohorts and compared outcomes of patients who received or did not receive adjuvant chemotherapy. FINDINGS: The deep-learning model achieved a high diagnostic accuracy for assessing tumour stroma in both internal validation cohort one (area under the receiver operating characteristic curve [AUC] 0·96-0·98]) and external validation cohort one (AUC 0·89-0·94). The stromal imaging signature was significantly associated with disease-free survival and overall survival in all cohorts (p<0·0001). The predicted stroma classes remained an independent prognostic factor adjusting for clinicopathological variables including tumour size, stage, differentiation, and Lauren histology. In patients with stage II or III disease in predicted stroma classes one and two subgroups, patients who received adjuvant chemotherapy had improved survival compared with those who did not (in those with stage II disease hazard ratio [HR] 0·48 [95% CI 0·29-0·77], p=0·0021; and in those with stage III disease HR 0·70 [0·57-0·85], p=0·00042). However, in the other two subgroups adjuvant chemotherapy was not associated with survival and might even be detrimental in the predicted stroma class 4 subgroup (HR 1·48 [1·08-2·03], p=0·013). INTERPRETATION: The deep-learning model could allow for accurate and non-invasive evaluation of tumour stroma from CT images in gastric cancer. The radiographical model predicted chemotherapy outcomes and could be used in combination with clinicopathological criteria to refine prognosis and inform treatment decisions of patients with gastric cancer. FUNDING: None.
BACKGROUND: The tumour stroma microenvironment plays an important part in disease progression and its composition can influence treatment response and outcomes. Histological evaluation of tumour stroma is limited by access to tissue, spatial heterogeneity, and temporal evolution. We aimed to develop a radiological signature for non-invasive assessment of tumour stroma and treatment outcomes. METHODS: In this multicentre, retrospective study, we analysed CT images and outcome data of 2209 patients with resected gastric cancer from five independent cohorts recruited from two centres (Nanfang Hospital of Southern Medical University [Guangzhou, China] and Sun Yat-sen University Cancer Center [Guangzhou, China]). Patients with histologically confirmed gastric cancer, at least 15 lymph nodes harvested, preoperative abdominal CT available, and complete clinicopathological and follow-up data were eligible for inclusion. Tumour tissue was collected for patients in the training cohort (321 patients), internal validation cohort one (246 patients), and external validation cohort one (128 patients). Four stroma classes were defined according to the protein expression of α-smooth muscle actin and periostin assessed by immunohistochemistry. The primary objective was to predict the histologically based stroma classes by using preoperative CT images. We trained a deep convolutional neural network model using the training cohort and tested the model in the internal and external validation cohort one. We evaluated the model's association with prognosis in the training cohort, two internal, and two external validation cohorts and compared outcomes of patients who received or did not receive adjuvant chemotherapy. FINDINGS: The deep-learning model achieved a high diagnostic accuracy for assessing tumour stroma in both internal validation cohort one (area under the receiver operating characteristic curve [AUC] 0·96-0·98]) and external validation cohort one (AUC 0·89-0·94). The stromal imaging signature was significantly associated with disease-free survival and overall survival in all cohorts (p<0·0001). The predicted stroma classes remained an independent prognostic factor adjusting for clinicopathological variables including tumour size, stage, differentiation, and Lauren histology. In patients with stage II or III disease in predicted stroma classes one and two subgroups, patients who received adjuvant chemotherapy had improved survival compared with those who did not (in those with stage II disease hazard ratio [HR] 0·48 [95% CI 0·29-0·77], p=0·0021; and in those with stage III disease HR 0·70 [0·57-0·85], p=0·00042). However, in the other two subgroups adjuvant chemotherapy was not associated with survival and might even be detrimental in the predicted stroma class 4 subgroup (HR 1·48 [1·08-2·03], p=0·013). INTERPRETATION: The deep-learning model could allow for accurate and non-invasive evaluation of tumour stroma from CT images in gastric cancer. The radiographical model predicted chemotherapy outcomes and could be used in combination with clinicopathological criteria to refine prognosis and inform treatment decisions of patients with gastric cancer. FUNDING: None.
Authors: Rami S Vanguri; Jia Luo; Andrew T Aukerman; Jacklynn V Egger; Christopher J Fong; Natally Horvat; Andrew Pagano; Jose de Arimateia Batista Araujo-Filho; Luke Geneslaw; Hira Rizvi; Ramon Sosa; Kevin M Boehm; Soo-Ryum Yang; Francis M Bodd; Katia Ventura; Travis J Hollmann; Michelle S Ginsberg; Jianjiong Gao; Matthew D Hellmann; Jennifer L Sauter; Sohrab P Shah Journal: Nat Cancer Date: 2022-08-29
Authors: Roger Sun; Théophraste Henry; Adrien Laville; Alexandre Carré; Anthony Hamaoui; Sophie Bockel; Ines Chaffai; Antonin Levy; Cyrus Chargari; Charlotte Robert; Eric Deutsch Journal: J Immunother Cancer Date: 2022-07 Impact factor: 12.469
Authors: Mark P Khurana; Daniel E Raaschou-Pedersen; Jørgen Kurtzhals; Jakob E Bardram; Sisse R Ostrowski; Johan S Bundgaard Journal: BMC Med Educ Date: 2022-02-26 Impact factor: 2.463
Authors: Jia Wu; Chao Li; Michael Gensheimer; Sukhmani Padda; Fumi Kato; Hiroki Shirato; Yiran Wei; Carola-Bibiane Schönlieb; Stephen John Price; David Jaffray; John Heymach; Joel W Neal; Billy W Loo; Heather Wakelee; Maximilian Diehn; Ruijiang Li Journal: Nat Mach Intell Date: 2021-08-09